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T-CELL LEUKAEMIA IN CHILDREN FROM THE
PROVINCE OF NAPLES
SIR,-Several reportsl-4 have focused on the relation between
some adult T-cell-derived malignancies and HTLV virus in the so-
called "endemic" areas-the west coast of Kyushu Island (Japan),
and the Caribbean.
Over a 30-month period (August, 1980, to February, 1983) we
studied 58 children with acute lymphoblastic leukaemia (ALL). 40,
all from the Campania region, were newly diagnosed cases.
Lymphoblasts were screened for sIg and E rosette formation, and 25
cases were analysed by a panel of monoclonal antibodies (the OKT
series, J- 5, B-1, p - 24 (BA-2), and OKIal). 16 (40%) of the 40
newly diagnosed cases were T-cell ALL. 7 T-cell ALL children
were studied by monoclonal antibodies (table).
While the regional distribution of non-T, non-B ALL cases was
heterogeneous and without significant characteristics, 13 of the
T-cell ALL cases came from the province of Naples; and 7 were
from small towns in the Mount Vesuvius area (Ercolano, Pompei,
Castellammare di Stabia), with 4 others from parts of the province
with similar geological characteristics (Campi Flegrei, Ischia,
Sorrento). Thus, most of the T-cell ALL cases arose in a small,
defined area. Our data suggest that the annual incidence of cases in
this area is three times greater than the mean incidence for the rest of
Italy.
Patients 4 and 5 came from Castellammare di Stabia; they lived
very near each other and went to the same school (a brother of one of
them was in the same class as the other). The disease onset in these
two cases was only a few days apart. A few months later another li1ltle
girl with T-cell ALL coming from Ercolano (very near
Castellammare) was admitted. She was the only one with a post-
thymic phenotype (T6 -, T4 -, T8). Two boys with T-cell ALL
living in Naples were also admitted almost simultaneously on the
first manifestation of the disease. These five cases had similar
clinical and haematological features.
These observations suggest the possibility of horizontal
transmission of T-cell ALL in these children. Virological studies
were not done.
As stressed in a 1982 Lancet editorials a worldwide search for
HTLV retrovirus in T-cell malignancies seems advisable. The
natural radioactivity of the area around Vesuvius is very high-135
mrem per person against 20 for the region and 7 for Italy (mean
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values). Japan, the Caribbean, and Italy (and Campania especially)
have geological features in common: they are all volcanic areas and
are sited along tectonic rifts.
Is the province of Naples a high-risk area for childhood T-cell
ALL? We are ready to cooperate with virologists and other
specialists who might wish to study our T-cell ALL patients and
their families.







PLATELET MONOAMINE OXIDASE ACTIVITY IN A
NEVER-TREATED CHRONIC SCHIZOPHRENIC
SIR,-Lowered platelet monoamine oxidase (MAO) activity has
been reported to be a discriminating characteristic of different
subgroups of schizophrenic patients, particularly those with
paranoid symptoms or auditory hallucinations. However, several
groupsl-4 have suggested that neuroleptic treatment may have
contributed significantly to the decreased platelet MAO found in
some studies of schizophrenic patients. Typically platelet MAO
activity during neuroleptic treatment has been compared with
values obtained during a preceding drug-free period, usually of
between one and six weeks. It is not clear whether such drug-free
periods are long enough to provide a stable baseline for biological
indices.2
We.have seen a 36-year-old man who met both research diagnostic
and DSM-III criteria for chronic paranoid schizophrenia, the onset
of which was independently confirmed to have occurred 4 years
previously. Remarkably, this delusional, hallucinating patient had
never received antipsychotic or psychotropic medication. His
parents’ involvement had moderated the more severe exacerbations
and psychiatric intervention had never been sought.
Before neuroleptic medication began platelet MAO activity was
18-49 nmol/l 08 platelets/h; the platelet count was 282 000/&micro;l. Alter
the patient had received seventeen daily doses of haloperidol (20 mg
for 3 days, 25 mg for 11 more days, then 20 mg for an additional 3
days), platelet MAO activity was 9-77 nmol/108 platelets/h; the
platelet count was 195 000/&micro;1. Laboratory personnel doing the
platelet MAO assays5 were "blind" to the patient’s diagnosis; blood
samples were analysed in duplicate; and the laboratory’s intra-assay
coefficient of variation is less than 5%.
After 17 days of treatment with haloperidol alone (which was
associated with clinical improvement), the patient’s platelet MAO
activity had fallen to 53% of its level before medication had been
administered. This marked decline in platelet MAO activity is
striking in view of the reported changes of only 15-20% in platelet
MAO activity during the course of repeated sampling studies and in
view of the even greater decrement in platelet MAO activity that
would have been calculated if the platelet count had not been lower
at the time of the second blood sample. That we found such a
decrease in a never-medicated patient lends support to the
assumption that the brevity of the drug-free periods used in earlier
studies of the effect ofneuroleptics on platelet MAO activity did not
confound the similar results obtained.
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